Delivery Order SPE2DB20D6037-SPE2DB24FTUU8
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,978.75 contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML and has a completion date of July 9, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $15,032.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the procurement of BEYFORTUS 100 MG/ML SYRINGEML, with a completion date of September 30, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which allows...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $18,107.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which runs through February 2, 2024, is for the supply of the pharmaceutical product BEYFORTUS 100 MG/ML SYRINGEML. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a significant indefinite delivery contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,573.50, is for the delivery of the pharmaceutical product BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $11,407.06 and is for the supply of the pharmaceutical product BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The contract is a firm fixed-price delivery order with no set-aside designation. It is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $50,490.00 firm fixed-price contract is for the delivery of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, with a period of performance through August 28, 2023. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, valued at $5,432.31, is for the delivery of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 2, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that has previously held indefinite delivery contracts with DLA to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical distributor based in Park Ridge, Illinois. The $90,538.50 firm fixed-price contract is for the delivery of BEYFORTUS 100 mg/mL syringes. The award has no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract 4600082013 under the DLA's SPE2DB program, valued up to $4,999,999 through 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,332.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 24, 2025. The contract calls for delivery of Beyfortus 50 mg/0.5 ml syringes and is structured as a firm fixed-price delivery order with an ultimate completion date of September 25, 2025. Performance will occur in Conshohocken, Pennsylvania. This award was made without a set-aside designation, allowing DMS Pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,711.25 delivery order is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order and is not associated with a set-aside designation. DMS Pharmaceutical...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB24FTUU8Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The order, valued at $4,656.24, is for the supply of the drug Beyfortus 100 mg/ml syringe. The contract has a firm fixed-price pricing type and an ultimate completion date of March 4, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current delivery order is part of this larger contract vehicle. The contract does not have a set-aside designation, but DMS Pharmaceutical Group's status as a woman-owned small business likely contributed to its selection for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 3/1/24 |